"10.1371_journal.pone.0064774","plos one","2013-05-29T00:00:00Z","Kjetil H Løland; Øyvind Bleie; Heidi Borgeraas; Elin Strand; Per M Ueland; Asbjørn Svardal; Jan E Nordrehaug; Ottar Nygård","Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Heart Disease, Haukeland University Hospital, Bergen, Norway; Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway","Conceived and designed the experiments: ON JEN PMU OB. Performed the experiments: ON OB KHL ES AS. Analyzed the data: KHL HB OB ES PMU AS JEN ON. Contributed reagents/materials/analysis tools: ES AS. Wrote the paper: KHL HB OB ON PMU.","The main sponsors were nonprofit organizations with no participating role in the trial. Alpharma Inc provided the study capsules, generated the randomization sequence, and concealed the randomization code free of charge and rendered a limited grant to finance the initial phase of the trial. However, Alpharma Inc had no role in the design or implementation of the trial, had no access to study data, and did not participate in data analysis or interpretation or in the preparation, review, or approval of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Kjetil H Løland","KHL",8,TRUE,4,5,8,5,TRUE,TRUE,TRUE,1,"2",FALSE
